Clinical Trial Update: A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis [Phase 2]

View source ↗

Summary

The Phase 2 Nipocalimab trial in adults with active lupus nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lupus Nephritis | Phase 2 | Status: WITHDRAWN